Bristol-Myers Squibb beat Q4 earnings expectations, but the stock fell due to lowered 2025 revenue guidance and patent ...

Unlike the cash-rich tech giants that don’t need lower interest rates, small caps benefit tremendously from falling rates.

The server maker's shares have climbed more than 30% over the past four days, powered higher by two bits of good news.